A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi ...

Shortages to backbone chemotherapy drugs are negatively affecting patient care, and more shortages are likely without policy solutions, experts say.

A positive trend in overall survival was observed, favoring sacituzumab govitecan over chemotherapy, though data is still ...

Chemotherapy may soon take a backseat. Experts say targeted therapies—drugs that attack cancer at the genetic level—are ...

Izalontamab (SI-B001), a novel EGFR/HER3 bispecific monoclonal antibody, was well-tolerated and exhibited preliminary ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

After years of being displaced following Hurricane Laura, Christus Ochsner Lake Area has officially launched its new infusion ...

MUMBAI: A low-cost, platinum-based chemotherapy drug, carboplatin, can now be utilised to increase chances of survival among women with aggressive breast cancer, as per a 10-year-long study and ...

Advancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track consideration ...

The oncology adjuvants market is expanding due to rising cancer rates, personalized medicine demand, and advances in ...

Detailed price information for Beone Medicines Ltd (ONC-Q) from The Globe and Mail including charting and trades.

A new study has found for the first time that magnetoelectric nanoparticles—tiny, wirelessly controlled particles activated ...